Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOS
· Real-Time Price · USD
3.12
-0.23 (-6.87%)
At close: Sep 26, 2025, 3:59 PM
3.20
2.56%
After-hours: Sep 26, 2025, 07:48 PM EDT
Vivos Therapeutics Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|---|
| Appliances Revenue | 1.03M | 1.27M | 1.3M | 1.58M | 1.58M | 1.15M |
| Appliances Revenue Growth | -19.25% | -1.85% | -18.07% | +0.44% | +37.64% | n/a |
| Billing Intelligence Services Revenue | 190K | 181K | 196K | 206K | 213K | 225K |
| Billing Intelligence Services Revenue Growth | +4.97% | -7.65% | -4.85% | -3.29% | -5.33% | n/a |
| Product Revenue | 1.89M | 1.81M | 2.27M | 1.96M | 1.98M | 1.67M |
| Product Revenue Growth | +3.97% | -20.03% | +15.78% | -0.86% | +17.98% | n/a |
| Service Revenue | 1.94M | 1.2M | 1.43M | 1.9M | 2.08M | 1.75M |
| Service Revenue Growth | +60.85% | -15.93% | -24.76% | -8.51% | +19.14% | n/a |
| Sponsorship Seminar Other Revenue | 608K | 328K | 1.3M | 294K | 224K | 122K |
| Sponsorship Seminar Other Revenue Growth | +85.37% | -74.79% | +342.52% | +31.25% | +83.61% | n/a |
| VIP Revenue | 130K | 223K | n/a | 926K | 1.17M | 907K |
| VIP Revenue Growth | -41.70% | n/a | -100.00% | -21.12% | +29.44% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.67M | 5.25M | 4.76M | 4.83M | 4.44M | 5.58M | 6.07M | 5.24M | 6.47M | 7.17M | 8.28M | 7.73M | 9.39M | 9.03M | 9.44M | 8.49M | 7.49M | 5.92M | 5.43M | 4.22M | 3.96M | 4.79M | 4.54M | 5.43M | 4.26M | 4.26M |
| Selling, General, and Administrative Revenue Growth | +27.03% | +10.32% | -1.53% | +8.80% | -20.34% | -8.18% | +15.96% | -19.02% | -9.77% | -13.42% | +7.12% | -17.70% | +4.01% | -4.36% | +11.14% | +13.38% | +26.55% | +9.06% | +28.59% | +6.50% | -17.31% | +5.61% | -16.42% | +27.53% | 0.00% | n/a |
| Research and Development Revenue | n/a | n/a | 100K | n/a | n/a | 100K | 100K | 100K | 100K | n/a | n/a | n/a | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | n/a | n/a | -100.00% | 0.00% | 0.00% | 0.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 260K | 358K | 412K | 346K | 320K | 655K | 606K | 641K | 590K | 630K | 1.35M | 1.11M | 1.7M | 753K | 1.32M | 1.98M | 1.4M | 860.16K | 820.29K | 431.7K | 502.19K | 559.84K | 485.32K | 859.38K | 483.02K | 483.02K |
| Sales and Marketing Revenue Growth | -27.37% | -13.11% | +19.08% | +8.12% | -51.15% | +8.09% | -5.46% | +8.64% | -6.35% | -53.51% | +22.51% | -34.90% | +125.63% | -42.80% | -33.38% | +41.36% | +62.53% | +4.86% | +90.01% | -14.04% | -10.30% | +15.35% | -43.53% | +77.92% | 0.00% | n/a |